Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
|
|
NeuBase Therapeutics, Inc. (OHRP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/10/2022 |
3
| Branning Todd P. (CFO) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 01/05/2022 |
3
| Ende Eric J (Director) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 05/25/2021 |
3
| Rojas-Caro Sandra (Chief Medical Officer) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 05/25/2021 |
3
| Motesharei Kianoush (See Remarks) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 05/13/2021 |
3
| McDougall Gerald J (Director) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 12/02/2020 |
3
| Bradshaw Curt (Chief Scientific Officer) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 07/28/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/16/2019 |
3
| Miralles Gines Diego (Director) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 07/16/2019 |
3
| PRENDERGAST FRANKLYN G (Director) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 07/16/2019 |
3
| RICHMAN ERIC I (Director) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 07/16/2019 |
3
| GOLDSTEIN DOV A MD (Director) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 07/16/2019 |
3
| Stephan Dietrich A (President and CEO) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 05/16/2017 |
3
| Ferguson Michael (Director) has filed a Form 3 on Ohr Pharmaceutical Inc |
| 06/28/2013 |
3
| Riedhammer Thomas M (Director) has filed a Form 3 on Ohr Pharmaceutical Inc |
| 06/24/2013 |
3
| GREENSTEIN IRA A (Chairman of the Board) has filed a Form 3 on Ohr Pharmaceutical Inc |
| 06/24/2013 |
3
| Almenoff June Sherie (Director) has filed a Form 3 on Ohr Pharmaceutical Inc |
| 06/24/2013 |
3
| Taraporewala Irach B. (CEO & President) has filed a Form 3 on Ohr Pharmaceutical Inc |
| 06/24/2013 |
3
| Backenroth Samuel (CEO & VP of Bus. Development) has filed a Form 3 on Ohr Pharmaceutical Inc |
|
|